Daiichi Sankyo Co., Ltd./ US23381D1028 /
6/5/2024 3:57:11 PM | Chg. +1.0185 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
35.8100USD | +2.93% | 20,772 Turnover: 708,687.2700 |
-Bid Size: - | -Ask Size: - | 36.0000 | 34.9800 |
GlobeNewswire
6/4
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Pres...
GlobeNewswire
5/22
First-In-Class Cholesterol-Lowering Treatment NILEMDO® (NEXLETOL® in the U.S.) and Its Combination w...
GlobeNewswire
5/1
Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...
GlobeNewswire
4/29
Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Eva...
GlobeNewswire
3/29
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
GlobeNewswire
3/22
CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose ...
GlobeNewswire
2/15
Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire
1/3
Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including...
GlobeNewswire
11/29/2023
INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breas...
GlobeNewswire
11/28/2023
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
GlobeNewswire
11/2/2023
Ultragenyx Reports Third Quarter 2023 Financial Results and Corporate Update
GlobeNewswire
10/2/2023
Prevent Cancer Foundation raises more than $2 million for cancer prevention and early detection at a...
GlobeNewswire
9/27/2023
CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal includ...
GlobeNewswire
9/13/2023
Myricx Expands its Leadership Team with the Appointment of Dr. Robert McLeod as VP Clinical Developm...
GlobeNewswire
8/31/2023
RAIN Investors: Contact Robbins LLP for Information Regarding the Pending Lead Plaintiff Deadline in...
GlobeNewswire
3/24/2022
Glycotope Announces New Strategy to Maximize Potential of Uniquely-Tumor Specific Antibody Platform
GlobeNewswire
3/7/2022
Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise